PAUL J HASTINGS
CIK 1309702 · Chief Executive Officer · last filed 2026-06-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.21M
Companies
6
Total Filings
84
Lifetime Open-Market Net
-$3.94M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NKTX | Chief Executive Officer | 390,247 | $2.22 | $866.3K | -$1.59M | 22 | 2026-06-22 |
| ENGNW | Director | — | $0.36 | — | $0 | 3 | 2026-06-17 |
| PCRX | Director | 12,724 | $26.81 | $341.1K | -$2.27M | 30 | 2024-06-13 |
| PRTO | Director | — | $27.04 | — | $0 | 3 | 2018-06-11 |
| Relypsa Inc (RLYP) Delisted | Director | 0 | — | — | -$69.9K | 5 | 2016-09-02 |
| VIACELL INC (VIAC) Delisted | Director | — | $29.58 | — | $0 | 1 | 2007-06-01 |
Recent Filings · Page 4 of 9
84 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-19 | NKTX | Grant (A) | +41,900 | $0 | EDGAR |
| 2021-10-01 | NKTX | Sell (S) | −8,500 | -$231.1K | EDGAR |
| 2021-06-23 | NKTX | Sell (S) | −8,500 | -$226.2K | EDGAR |
| 2021-06-11 | PCRX | Grant (A) | +1,066 | $0 | EDGAR |
| 2021-06-08 | PCRX | Sell (S) | −630 | -$39.2K | EDGAR |
| 2021-04-01 | NKTX | Sell (S) | −17,000 | -$522.5K | EDGAR |
| 2021-03-09 | PCRX | Mixed | — | -$155.7K | EDGAR |
| 2021-01-12 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2020-07-13 | NKTX | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | PCRX | Grant (A) | +1,260 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.